143 results on '"Christian, Sven"'
Search Results
2. [Inaudible]
3. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles
4. The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies
5. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity
6. Acetyl-CoA Carboxylase 1-Dependent Protein Acetylation Controls Breast Cancer Metastasis and Recurrence
7. Nucleolin Expressed at the Cell Surface Is a Marker of Endothelial Cells in Angiogenic Blood Vessels
8. Supplementary Data from Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant Melanoma
9. Data from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
10. Supplementary Figure 4 from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
11. Supplementary Figure 1 from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
12. Supplementary Figure 3 from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
13. Supplementary Figure 2 from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
14. Supplementary Methods and Materials, Figure Legends 1-4 from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
15. TRPC6 channels modulate the response of pancreatic stellate cells to hypoxia
16. Angiogenese
17. Abstract 2682: Small molecule targeting the lipoic acid post-translational modification impacts proliferation of colorectal and PIK3CA-mutant cell lines
18. Abstract 3588: Discovery of potent and selective CSNK1A1 inhibitors for solid tumor therapy
19. Between Pop and Expressionism
20. Identification of the Highly Active, Species Cross-Reactive Complex I Inhibitor BAY-179
21. Abstract 2077: Activity of DHODH inhibitor BAY2402234 in subcutaneous and intracranial models of SCLC
22. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions
23. Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature
24. SLC25A32 sustains cancer cell proliferation by regulating flavin adenine nucleotide (FAD) metabolism
25. Cloning and characterization of Dlk, a novel serine/threonine kinase that is tightly associated with chromatin and phosphorylates core histones
26. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity
27. Abstract 3599: BAY 2402234: Preclinical evaluation of a novel, selective dihydroorotate dehydrogenase (DHODH) inhibitor for the treatment of colorectal carcinomas
28. Abstract 2: Discovery of BAY 2402234 by phenotypic screening: A human Dihydroorotate Dehydrogenase (DHODH) inhibitor in clinical trials for the treatment of myeloid malignancies
29. Abstract 3597: BAY 2402234: Preclinical evaluation of a novel, selective dihydroorotate dehydrogenase (DHODH) inhibitor for the treatment of diffuse large B-cell lymphoma (DLBCL)
30. Targeting a Therapy-Resistant Cancer Cell State Using Masked Electrophiles as GPX4 Inhibitors
31. Abstract 1453: SLC25A32 sustains cancer cell proliferation by regulating flavin adenine dinucleotide (FAD) metabolism
32. Abstract DDT02-04: BAY 2402234: A novel, selective dihydroorotate dehydrogenase (DHODH) inhibitor for the treatment of myeloid malignancies
33. Abstract 4989: 3D spheroid screen yields SCD1 pathway inhibitors for the treatment of cancer
34. Abstract 3248: Identification and optimization of a highly active, cross reactive Complex-1 inhibitor
35. Abstract 3086: Inhibitors of the enzyme dihydroorotate dehydrogenase, overcome the differentiation blockade in acute myeloid leukemia
36. Functional inhibition of acid sphingomyelinase by Fluphenazine triggers hypoxia-specific tumor cell death
37. Lysine acetylation in mitochondria: From inventory to function
38. THE MACHINE IN MY HEAD: AFTER A TRAUMATIC HEAD INJURY WHICH LEFT HIM IN A COMA, SELF-TAUGHT ARTIST BYRON EKSTEEN HAD TO RELEARN HOW TO MAKE SENSE OF THE WORLD AND IN DOING SO IMMERSED HIMSELF IN CREATIVE EXPRESSION.
39. Identification of KCa3.1 channel as a novel regulator of Oxidative phosphorylation in a subset of pancreatic carcinoma cell lines
40. Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell Lines
41. Abstract 223: Comparison of human-specific versus cross-reactive Complex I inhibitor for in vivo tumor efficacy
42. Are Metformin Doses Used in Murine Cancer Models Clinically Relevant?
43. Abstract PR01: Role of mitochondrial folate transporter in metabolism of tumor cells
44. SIAH ubiquitin ligases regulate breast cancer cell migration and invasion independent of the oxygen status
45. Abstract 1126: Differential effects of metformin and phenformin vs. other complex 1 inhibitors in vitro and in vivo
46. Abstract 317: 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions
47. Virale und gentherapeutische Ansätze zur Chemosensibilisierung und Immunpotenzierung des experimentellen Pankreaskarzinoms
48. Identifizierung und Charakterisierung von Endosialin, einem C-Typ Lektin-ahnlichen Rezeptor auf Tumorendothel
49. Abstract 4953: Stromal endosialin modulates the proinflammatory tumor microenvironment and is crucial for the growth of orthotopic pancreatic tumors.
50. Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell Lines.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.